Posts Tagged ‘singapore’
Launch of Nasodine promotion to HCPs in Singapore
Firebrick Pharma (ASX:FRE) is pleased to announce that it has executed a Marketing Representation Agreement with Singapore-based, Innorini Pte Ltd, trading as Innorini Life Sciences (“Innorini”). The initial term of the Agreement is one year with the option to renew for subsequent one-year terms by mutual agreement. Under the Agreement, Innorini will undertake “Marketing Services”…
Firebrick Consultant to drive Pharmacy Distribution in Singapore
Firebrick Pharma (ASX:FRE) is pleased to announce that it has executed a consulting agreement (Agreement) with Keith Shortall, a former senior executive of Johnson & Johnson Consumer Health Asia-Pacific (J&J Consumer Health APAC). The primary goal of the Agreement is to establish pharmacy distribution for Nasodine in Singapore. Secondary objectives include evaluating potential distribution to…
Firebrick Launches Nasodine in Singapore via Nasodine-sg.com
Firebrick Pharma Limited (ASX:FRE) is proud to announce that its product, Nasodine® Nasal Spray, is now available for sale in Singapore. Customers will be able to order the product through Firebrick’s new website dedicated to support Singapore sales: www.nasodine-sg.com In Singapore, Nasodine is classified as a topical antiseptic and does not require approval or licensing…